The largest database of trusted experimental protocols

Ileostomy

Ileostomy: A surgical procedure where a portion of the ileum (the last segment of the small intestine) is brought to the surface of the abdomen, allowing for the drainage of intestinal contents.
This technique is commonly used in the management of conditions such as ulcerative colitis, Crohn's disease, and colorectal cancer.
The ileostomy provides an alternative route for waste elimination when the rectum or colon is removed or no longer functioning properly.
Proper care and maintenance of the ileostomy is crucial to ensure optimal health outcomes and quality of life for patients undergoing this procedure.

Most cited protocols related to «Ileostomy»

Participants were drawn from 9 cross-sectional UK surveys comprising of the Scottish Health Surveys (SHS, 3 cohorts) and the Health Survey for England (HSE, 6 cohorts). Sampling individuals living in households in each country, all studies are representative of the general population. The characteristics of the individual cohorts are presented in table 1. The mean age at baseline ranged between 49 and 57 years, with women marginally comprising the majority of study members (range: 54-62%). Study participants gave full informed consent and ethical approval was obtained from the London Research Ethics Council or the Local Research Ethics Councils.
The full protocols for the HSE and SHS data collection have been described in detail elsewhere(15 ;16 ). In brief, study members were visited twice in their homes. During the first visit, trained interviewers collected data on demographics and health behaviours, including socioeconomic status (as indexed by occupational social class), self-reported smoking, and physical activity. During the second visit, conducted within a few days of the first, nurses gathered clinical data. In the seated position and after five minutes rest, systolic and diastolic blood pressure was measured on three occasions using an Omron HEM-907; an average of the second and third readings was used in the present analyses. Nurses also collected information about physician-diagnosed CVD (stroke, ischemic heart disease, angina symptoms), other medical conditions (hypertension and diabetes), and blood-pressure lowering medication (beta-blockers, angiotensin converting enzyme-inhibitors, diuretics, calcium blockers).
Height and weight were measured directly by the interviewers using Chasmors stadiometers (Chasmors Ltd., London, UK) and Tanita electronic digital scales (Tanita Incorporation, Japan), respectively. Body mass index (BMI) was calculated using the usual formulae (weight [kg]/height[m]2). Waist and hip circumferences were measured using a tape with an insertion buckle at one end. Waist circumference was measured at the midpoint between the lower rib and the upper margin of the iliac crest. Hip circumference was denoted by the widest circumference around the buttocks, below the iliac crest. Both measurements were taken twice, using the same tape, and were recorded to the nearest even millimetre. Those whose two waist or hip measurements differed by more than 3 cm had a third measurement taken. The mean of the two valid measurements was used in our analysis. For waist and hip measurements all those who reported that they had a colostomy or ileostomy, or were chairbound or pregnant, were excluded from the measurement. All those with measurements considered invalid by the nurse, for example due to refusals to remove excessive clothing or movement, were excluded from the analysis.
Publication 2011
Adrenergic beta-Antagonists Angina Pectoris Angiotensin-Converting Enzyme Inhibitors Blood Pressure Buttocks Calcium, Dietary Cerebrovascular Accident Colostomy Diabetes Mellitus Diuretics High Blood Pressures Households Ileostomy Iliac Crest Index, Body Mass Interviewers Movement Myocardial Ischemia Nurses Pharmaceutical Preparations Physicians Pressure, Diastolic Sitting Systole Waist Circumference Woman
Between July 2006 and April 2008, a series of patients with a presacral cavity after anastomotic leakage were treated by using the endo-sponge. All hospitals that had used the endo-sponge were contacted to collect data of experience with the endo-sponge. The endo-sponge had been used in patients following anastomotic leakage after low anterior resections for malignant disease or after restorative proctocolectomy with ileoanal pouch anastomosis for ulcerative colitis.
After surgery, when anastomotic leakage was suspected a computed tomography (CT) scan was performed in the majority of the cases. Using flexible endoscopy, the presence of an abscess cavity was confirmed. Subsequently a diverting stoma was routinely constructed when this had not been done during the primary operation. Primary outcome parameters were closure of the cavity and the ability to close the ileostomy. Factors associated with successful closure were analyzed, e.g., time of initiation of endo-sponge treatment after surgery, and experience with endo-sponge treatment (number of cases treated).
Approval of the Medical Ethics Committees was not necessary, since in the Netherlands for nonexperimental clinical case series such as this approval is not required.
Publication 2008
Abscess Anastomotic Leak Dental Caries Endometriosis Endoscopy Ethics Committees Ileostomy Operative Surgical Procedures Patients Porifera Proctocolectomy, Restorative Radionuclide Imaging Surgical Anastomoses Surgical Stoma Ulcerative Colitis X-Ray Computed Tomography
We first validated ICD-10-CM coding for CD diagnosis among hospitalized patients and CCI coding for surgical resections. Population-based surveillance was conducted in the CHZ between January 1 and December 31, 2011 to identify all adults (≥18 years) admitted to hospital with a diagnostic code for CD (ICD-10-CM K50.X). All patients with CD who underwent an intestinal resection in 2011 were included for the validation study. A negative control population was created by randomly sampling 200 patients with CD who were admitted to hospital but did not undergo an intestinal resection surgery. We validated administrative coding for 2011 because hospital records (including discharge summaries and operative reports) became available electronically after this time; using the electronic records allowed for more accurate capture of surgical procedures and hospitalization details for validation.
Surgical resection codes were defined a priori and stratified by CCI group: partial small intestine excisions including ileocecal resection (1.NK.87), partial large intestine excision (1.NM.87), total large intestine excision including total abdominal colectomy (1.NM.89, 1.NM.91), partial rectal excision including rectosigmoid resection (1.NQ.87), and total rectal excision including proctocolectomy (1.NQ.89). We specifically wanted to capture intestinal resection surgeries. We excluded relatively less invasive procedures with a lower burden of patient morbidity, including endoscopic procedures, “second-step” operations (e.g., pouch formation, completion proctectomy, ileostomy reversal), isolated perianal surgery, and abscess drainage. A complete list of administrative codes included and excluded from this study are found in Supplementary Tables 1 and 2.
Administrative database codes were then validated against comprehensive chart review for CD diagnosis, disease location (small intestine, large intestine, small and large intestine), surgical urgency (elective vs. non-elective), surgical approach (open vs. laparoscopic), and post-surgical anatomy (primary anastomosis vs. stoma). Surgery was defined as elective if the decision to operate was made prior to hospital admission. In contrast, the decision for emergent or urgent surgery occurred during the admission (e.g., after non-response to medical therapy or in response to life-threatening CD complications). Laparoscopic surgery requiring intra-operative conversion to open approach was classified as an open laparotomy.
For validation of administrative coding for CD diagnosis among hospitalized patients and for surgical resection, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) with 95% confidence intervals (CIs) were calculated.
Publication 2017
Abdomen Abscess Adult CD 200 Colectomy Diagnosis Drainage Hospitalization Hypersensitivity Ileostomy Intestines Intestines, Small Laparoscopy Laparotomy Large Intestine Operative Surgical Procedures Patient Discharge Patients Proctectomy Proctocolectomy Surgical Anastomoses Surgical Endoscopy Surgical Procedures, Laparoscopic Surgical Stoma Therapeutics

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2017
Abdomen Abdominal Pain Adenoma Adenomatous Polyposis Coli Diagnosis Diarrhea Eligibility Determination Ethics Committees, Research Ileostomy Inflammatory Bowel Diseases Malignant Neoplasms Neoplasm Metastasis Patients Pelvis Therapeutics Woman
Each medical record, from pre-operative planning through 60 days post-operation, was assessed by a single, surgically-trained reviewer. Predictor and outcome variables were selected for extraction a priori based on clinical expertise and literature review. An exhaustive examination of each patient’s chart was performed, recording patient, operative, and post-operative factors. The date of surgery was considered the date of ileostomy creation; if ileostomy was created to deal with complications of a prior procedure, the patient was coded as having a history of previous surgery less than 60 days ago and the ileostomy creation date was considered the index surgical date. Charlson Comorbidity Index, a comorbidity summarization score linearly associated with 1-year mortality13 (link), and the modified Clavien-Dindo Complication scoring system, classifying post-operative complications by therapy required14 (link), was calculated for each patient.
Publication 2017
Ileostomy Operative Surgical Procedures Patients Physical Examination

Most recents protocols related to «Ileostomy»

When identifying an acute MOPC, specialized gastroenterologists and colorectal surgeons selected either SEMS or diverting loop ileostomy as a BTS, considering the location and severity of the obstructing lesion, availability of SEMS, and risk of perforation. In cases of SEMS, the location and etiology of acute bowel obstruction are revealed by colonoscopy after bowel cleaning with a simple enema. The guidewire was positioned under fluoroscopy, and suitable stents were placed according to the standard method (Fig. 1) [16 (link)]. All the SEMSs used were uncovered (BONASTENT, Seoul, Korea; or HANAROSTENT, Seoul, Korea) and had a diameter of 24 mm and length of 60, 80, 100, or 120 mm.
Loop ileostomy was performed using a routine surgical approach [17 ]. After the abdominal wall incision at the ileostomy site, the tension-free loop of the distal ileum was pulled out of the abdominal wall to create a stoma. The sutures were then placed for mature and evert loop ileostomy. Curative resection can be performed in eligible patients after decompression of the bowel. The time of surgery was determined according to the patients’ general condition and co-morbidities and the degree of edematous bowel at the time of BTS. The surgical method was either right hemicolectomy (RHC) or extended RHC, depending on the location of the tumor. Investigation of complications and short-term outcomes associated with SEMS insertion or diverting ileostomy was performed. The result of curative resection after BTS was also analyzed for the corresponding patients to evaluate the long-term effect of the two bridge modalities.
Publication 2023
Colonoscopy Decompression Edema Enema Fluoroscopy Gastroenterologist Hemicolectomy Ileostomy Ileum Intestinal Obstruction Intestines Longterm Effects Loop Ileostomies Neoplasms by Site Operative Surgical Procedures Patients Stents Surgeons Surgical Stoma Sutures Wall, Abdominal
Adult ileostomy patients without comorbidities were recruited for this interventions study, using specific in- and exclusion criteria (see Supplemental methods “recruitment criteria”). Importantly, to avoid confounding effects on the study endpoints, study subjects were not allowed to consume pro-, pre- or symbiotics, fresh dairy fermented products (such as yogurt, cottage cheese, buttermilk, or soft-raw cheeses) as well as other food products that are fermented (i.e. sauerkraut) during the study period and three months prior to participation in this trial (a list of forbidden products was provided).
Due to a lack of reliable prior art in the investigation of the impact of food-derived bacteria on the small intestinal microbiota, no effect size could be estimated or a priori power calculation could be performed. Therefore, the study was designed as an explorative study, aiming for the inclusion of 15 to 20 subjects fulfilling the inclusion criteria. We recruited 15 subjects with a standard ileostoma, and a single subject with a continent-ileostoma (i.e. Kock pouch). During data analysis, the SI microbiota of the latter individual was drastically different from the rest of the ileostomists and was therefore considered to be a biological outlier that was excluded from further analyses (see “Results” section).
Full text: Click here
Publication 2023
Adult Bacteria Biopharmaceuticals Buttermilk Cheese Food Ileostomy Intestinal Microbiome Kock Pouch Microbial Community Patients Yogurt
Ileostomy effluent samples collected for this analysis (see above) were thawed and homogenised while remaining cooled on ice using Ultra-Turrax t50 (IKA, Germany). Ten millilitres of the homogenised samples was transferred to a tube and larger debris was removed by low-speed centrifugation (3’, 500×g, 4 °C, with the centrifuge’s breaks switched off). Subsequently, bacteria and smaller-sized debris were pelleted by higher speed centrifugation (10’, 8000×g, 4 °C) and the pellet obtained was immediately resuspended in 100 μl of phenol–chloroform–isoamyl alcohol (pH 6.5–8.0, Sigma, Germany) followed by RNA extraction using the RNeasy PowerMicrobiome Kit (Qiagen, Germany) according to the manufacturer’s instructions. Extracted RNA was stored at – 80 °C. RNA quality and quantity were analysed by agarose gel electrophoresis as well as using the TapeStation 2200 (Agilent Technologies, CA, USA). Obtaining RNA of sufficient quality in these samples was challenging, resulting in a restricted and unbalanced sample size for this analysis. Most of the successfully sequenced samples were taken at the start or end of the fermented product intervention periods and only for three subjects a complete sample set (all 6 samples) could be analysed. The 250~300 bp insert cDNA library with rRNA removal (Ribo-ZeroTM Magnetic Kit, Illumina, USA) and sequencing were performed by Novogene (Hong Kong) using the HiSeq2500 platform (PE150, 12 G raw data/sample). HUMAnN2, with the default settings [35 (link)], was used for the functional profiling of the metatranscriptome datasets by mapping against UniRef90 protein database (updated global profiling of the Human Microbiome Project [36 (link)]) and MetaCyc database 19.1 [37 (link)] to obtain the bacterial pathway abundances (Functional Metatranscriptome Mapping) combined with taxonomic profiling by the included taxonomic identification tool MetaPhlAn2.
Full text: Click here
Publication 2023
Bacteria cDNA Library Centrifugation Chloroform Electrophoresis, Agar Gel Human Microbiome Ileostomy isopentyl alcohol Phenols Ribosomal RNA

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Age Groups atresia Child Cholestasis Chromosome Aberrations Congenital atresia of the small intestine Congenital Heart Defects Cystic Fibrosis Deficiency Diseases Diagnosis Electrolytes Enterostomy Fistula Hemodynamics Homozygote Ileocecal Valve Ileostomy Ileum Ileus, Meconium Infant Infant, Newborn Intestinal Perforation Intestines Jejunostomy Jejunum Legal Guardians Malabsorption Syndrome Mucus Necrotizing Enterocolitis Ostomy Parent Parenteral Nutrition Patients Pharmaceutical Preparations Second Look Surgery Syndrome Vitamins Youth
In the second half of 2018, our group innovatively introduced the TLAP technique into ileostomy reversal. Since then, TLAP has been performed in >10 procedures/year by the same surgery team. From October 2018 to October 2021, a total of 65 consecutive patients were retrospectively enrolled. All patients with a history of laparoscopic colorectal cancer surgery underwent TLAP at the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.
In this study, any patients suited to undergo classic open reversal were regarded as potential candidates for TLAP. Eligible patients were those ≥18 years of age who received TLAP ≥3 months after former colorectal surgery or 8 weeks after postoperative chemotherapy/radiotherapy. Moreover, study participants also underwent both a colonoscope examination and enhanced computed tomography imaging of the thoracic, abdominal, and pelvic cavities to guarantee acceptable anastomotic stoma healing and exclude tumor recurrence or metastasis. Patients who underwent TLAP combined with additional procedures, such as additional intestine resection, anastomotic reconstruction, or parastomal hernia/abdominal wall repair, and those with other surgical contradictions for the traditional open ileostomy reversal were excluded from subsequent analysis. This study was in accordance with the Declaration of Helsinki and the informed contents were signed before the TLAP surgery. This research was also approved by the Ethical Committee of the Cancer Hospital (Institute), Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Full text: Click here
Publication 2023
Abdomen Abdominoplasty Chinese Colonoscopes Colorectal Carcinoma Hernia Ileostomy Intestines Malignant Neoplasms Neoplasm Metastasis Neoplasms Operative Surgical Procedures Patients Pelvis Pharmacotherapy Radiotherapy Reconstructive Surgical Procedures Recurrence Surgical Anastomoses Surgical Procedures, Laparoscopic Surgical Stoma X-Ray Computed Tomography

Top products related to «Ileostomy»

Sourced in United States, Japan, United Kingdom, Germany, Belgium, Austria, China, Spain, Ireland
SPSS version 24 is a statistical software package developed by IBM. It provides a comprehensive set of tools for data analysis, including techniques for descriptive statistics, regression analysis, and predictive modeling. The software is designed to help users interpret data, identify trends, and make informed decisions based on statistical insights.
Sourced in United States, United Kingdom
The Human Gene 1.0 ST Array is a microarray platform designed for comprehensive gene expression analysis. It provides a comprehensive coverage of the human transcriptome, enabling researchers to study genome-wide expression changes. The array features over 28,000 well-annotated genes, with multiple probes per gene to ensure robust and reliable data.
Sourced in United States, United Kingdom, Germany, Japan, Lithuania, Italy, Australia, Canada, Denmark, China, New Zealand, Spain, Belgium, France, Sweden, Switzerland, Brazil, Austria, Ireland, India, Netherlands, Portugal, Jamaica
RNAlater is a RNA stabilization solution developed by Thermo Fisher Scientific. It is designed to protect RNA from degradation during sample collection, storage, and transportation. RNAlater stabilizes the RNA in tissues and cells, allowing for efficient RNA extraction and analysis.
Sourced in United States
OCT freezing medium is a laboratory product designed for use in frozen tissue sectioning. It is a clear, water-soluble liquid that helps stabilize and support tissue samples during the freezing process, enabling thin, uniform sections to be obtained for microscopic analysis.
Sourced in United States
Quetol651 is a resin embedding medium for electron microscopy. It is a low viscosity epoxy resin formulation designed for the embedding and sectioning of biological samples for transmission electron microscopy analysis.
Sourced in United States, Germany, United Kingdom
Interleukin-23 (IL-23) is a cytokine that plays a role in inflammatory and autoimmune processes. It is a heterodimeric protein composed of a p19 subunit and a p40 subunit. IL-23 is involved in the differentiation and expansion of Th17 cells, which produce inflammatory cytokines. It is expressed by activated dendritic cells and macrophages.
Sourced in United States, Belgium, Germany, Finland, Sweden, United Kingdom, Norway, Switzerland, Brazil, Ireland, Denmark, Canada, Australia
Ketalar is a general anesthetic medication used to induce and maintain anesthesia. It is a clear, colorless, water-soluble compound that is administered via injection. The active ingredient in Ketalar is the chemical compound ketamine hydrochloride.
Sourced in Japan, United States, Germany, Spain
The DP70 is a digital camera designed for microscopy applications. It features a high-resolution CCD sensor and captures digital images that can be used for documentation, analysis, and sharing. The DP70 is compatible with various Olympus microscopes and provides a direct digital imaging solution for laboratory settings.
Sourced in United States, United Kingdom, Japan, Thailand, China, Italy, Germany
SPSS version 18.0 is a statistical software package developed by IBM. It provides data management, analysis, and reporting capabilities. The core function of SPSS is to assist in the analysis of data and presentation of results.
Sourced in United States, Germany, United Kingdom, Belgium, Japan, China, Austria, Denmark
SPSS v20 is a statistical software package developed by IBM. It provides data management, analysis, and visualization capabilities. The core function of SPSS v20 is to enable users to perform a variety of statistical analyses on data, including regression, correlation, and hypothesis testing.

More about "Ileostomy"

Ileostomy is a surgical procedure where a portion of the ileum (the last segment of the small intestine) is brought to the surface of the abdomen, allowing for the drainage of intestinal contents.
This technique is commonly used in the management of conditions such as ulcerative colitis, Crohn's disease, and colorectal cancer.
The ileostomy provides an alternative route for waste elimination when the rectum or colon is removed or no longer functioning properly.
Proper care and maintenance of the ileostomy is crucial to ensure optimal health outcomes and quality of life for patients undergoing this procedure.
Ileostomies can be temporary or permanent, depending on the patient's medical condition and treatment plan.
Temporary ileostomies are often used as a way to allow the colon or rectum to heal after surgery, while permanent ileostomies are typically used when the colon or rectum has been removed or is no longer functioning properly.
The ileus, a temporary paralysis of the intestines, is a common complication of ileostomy surgery.
Patients may also experience other complications, such as skin irritation, leakage, and blockages.
Regular monitoring and proper care of the ileostomy, including the use of specialized equipment like SPSS version 24, Human Gene 1.0 ST Array, RNAlater, OCT freezing medium, Quetol651, IL-23, Ketalar, and DP70 digital cameras, can help to prevent and manage these complications.
Ileostomy patients may also need to adjust their diet and fluid intake to maintain their health and prevent complications.
SPSS version 18.0 and SPSS v20 can be used to analyze data and monitor patient outcomes.
Overall, ileostomy is a critical surgical intervention that can improve the quality of life for patients with certain gastrointestinal conditions.
By understanding the process, potential complications, and specialized equipment involved, healthcare providers and patients can work together to ensure the best possible outcomes.